Starpharma

Gain a direct line to Starpharma's leadership


Be first to know our latest company updates


Watch exclusive videos accompanying major
news

Home

Our Brands

Team

Research Publications

Our Capabilities

About Starpharma

Company

DEP® Drug Delivery Platform

Dendrimer Technology

DEP® Solutions

Pipeline & Products

Corporate Governance

Shareholder Services

Stock Listing

Market Data

Annual General Meeting 2025

Annual Reports

Video Library

Investor Presentations

Updates

ASX Announcements

Why Invest

Announcements

Careers

Our People & Culture

People & Culture

Star Navigator

Starpharma Partnerships

Partnerships

Poppins

upload.jpg

What an insightful week Starpharma had at iSRS 2025! 

Starpharma joined over 600 attendees from industry and academia at the recent 26th International Symposium on Radiopharmaceutical Sciences on the Gold Coast, diving into the latest in radioisotope production and radiopharmaceutical development.

“It was incredibly valuable to hear from top scientists and connect with our peers in the radiopharmaceutical space. We gathered insights about new strategies in oncology, which will help us advance Starpharma's DEP® radiopharmaceutical programs”, said Dr Brian Kelly, Starpharma’s Director of Manufacture and Laboratory Operations. 

It was also great to see our collaborators at the UQ ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) present both oral presentations and scientific posters demonstrating their continued valuable contributions to this exciting sector. 

Radiochemistry is a rapidly evolving field, and we believe our highly versatile dendrimer technology is well positioned to unlock exciting new opportunities and contribute to the future of radiopharmaceuticals.

Starpharma at iSRS 2025